Brought to you by:
Digging deep into DOACs for PAD post-revascularization in fight to stave off amputation
This advertorial is sponsored by ACHL. “It’s really sad—but it’s true: In the PAD [peripheral arterial disease] space, we’re really behind. We’re behind in our understanding of the physiology, the anatomy to some extent, the way the disease permeates through the…
Combining aspirin with rivaroxaban reduces risk equally in presence or absence of diabetes
In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative degree of benefit on coronary, cerebrovascular and peripheral endpoints in patients with and without diabetes, a prespecified analysis of the COMPASS trial has shown. It also noted…